Skip to main navigation Skip to search Skip to main content

Selective extracellular signal-regulated kinase 1/2 (ERK1/2) inhibition by the SCH772984 compound attenuates in vitro and in vivo inflammatory responses and prolongs survival in murine sepsis models

  • Michal Kopczynski
  • , Izabela Rumienczyk
  • , Maria Kulecka
  • , Małgorzata Statkiewicz
  • , Kazimiera Pysniak
  • , Zuzanna Sandowska-Markiewicz
  • , Urszula Wojcik-Trechcinska
  • , Krzysztof Goryca
  • , Karolina Pyziak
  • , Eliza Majewska
  • , Magdalena Masiejczyk
  • , Katarzyna Wojcik-Jaszczynska
  • , Tomasz Rzymski
  • , Karol Bomsztyk
  • , Jerzy Ostrowski
  • , Michal Mikula
  • Maria Sklodowska-Curie Institute of Oncology
  • Medical Centre for Postgraduate Education, Warsaw
  • University of Warsaw
  • Ryvu Therapeutics S.A.
  • University of Washington

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Selective extracellular signal-regulated kinase 1/2 (ERK1/2) inhibition by the SCH772984 compound attenuates in vitro and in vivo inflammatory responses and prolongs survival in murine sepsis models'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science